Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Covington
Argus Health
Medtronic
Julphar
US Army
Teva
Farmers Insurance
Deloitte
US Department of Justice

Generated: October 23, 2017

DrugPatentWatch Database Preview

MEXATE-AQ Drug Profile

« Back to Dashboard

What is the patent landscape for Mexate-aq, and what generic Mexate-aq alternatives are available?

Mexate-aq is a drug marketed by Bristol Myers and Bristol Myers Squibb and is included in two NDAs.

The generic ingredient in MEXATE-AQ is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.

Summary for Tradename: MEXATE-AQ

US Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list125
Clinical Trials: see list30
Patent Applications: see list9,321
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MEXATE-AQ at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers
MEXATE-AQ
methotrexate sodium
INJECTABLE;INJECTION088760-001Feb 14, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
MEXATE-AQ PRESERVED
methotrexate sodium
INJECTABLE;INJECTION089887-001Apr 14, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Daiichi Sankyo
Dow
Queensland Health
Cantor Fitzgerald
Baxter
Julphar
Chubb
Chinese Patent Office
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot